发明名称 |
Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophy |
摘要 |
The present invention relates to the use of specific EGF-receptor antagonists for preparing a pharmaceutical composition for the prevention and/or treatment of benign prostatic hyperplasia and/or prostatic hypertrophy, a method for the treatment or prevention of benign prostatic hyperplasia/prostatic hypertrophy comprising administering an EGF-receptor antagonist of groups (A), (B) or (C), described herein optionally in combination with known compounds for the treatment of benign prostatic hyperplasia/prostatic hypertrophy, as well as associated pharmaceutical compositions. |
申请公布号 |
US8431585(B2) |
申请公布日期 |
2013.04.30 |
申请号 |
US20100706819 |
申请日期 |
2010.02.17 |
申请人 |
SINGER THOMAS;PLATZ STEFAN;COLBATZKY FLORIAN;BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
发明人 |
SINGER THOMAS;PLATZ STEFAN;COLBATZKY FLORIAN |
分类号 |
A61K31/517;A61K39/395;A61K31/47;A61K31/4706;A61K31/519;A61K31/5377;A61P13/08 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|